BRCA1 and neoplasm: Considering this evidence, our findings showing that DHA supplementation determines increased levels of RvD1 and RvD2 in specific subgroups—such as BRCA1/2-mutated patients—may reflect the activation of endogenous pro-resolving and anti-tumor pathways.